Trending Now
Alaunos Therapeutics Inc (NASDAQ: TCRT) Doses Its First Patient in a...
Alaunos Therapeutics Inc (NASDAQ: TCRT) has dosed its first patient in the Phase I/II study. The trial targets EGFR, TP53, and KRAS mutations for...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Cocrystal Pharma Inc (NASDAQ: COCP)’s SARS-CoV-2 3CL Protease Lead CDI-45205 Demonstrates...
The SARS-CoV-2 3CL protease lead CDI-45295 and several analogs of Cocrystal Pharma Inc (NASDAQ: COCP) showed potent in broad-spectrum vitro activity against the SARS-CoV-2...
MAKE IT MODERN
LATEST REVIEWS
Which Cannabis Stocks Will Benefit from the Coming Tailwind (SNDL, CBGL,...
Might cannabis stocks be set up as a value segment in the market?
We have seen recent legislative progress...
MAKE IT MODERN
PERFORMANCE TRAINING
GBT Technologies (GTCH) goal is to use its AI technology to overcome long range...
The global artificial intelligence market is on track to hit more than $554 billion in total revenue by 2024, according to market...
uniQure N.V. (NASDAQ: QURE) Doses First Two Subjects In the EU Clinical Study of...
uniQure N.V. (NASDAQ: QURE) has announced the dosing of the first two subjects in the European phase Ib/II clinical; study of AMT-130 in Europe....
ARCA Biopharma Inc. (NASDAQ:ABIO) Announces That It Has Received IND Application Approval For AB201...
ARCA Biopharma Inc. (NASDAQ:ABIO) has announced that it has received FDA approval for its Investigational New Drug application for AB201 (rNAPc2) as a potential...
Kintara Therapeutics Inc. (NASDAQ: KTRA) Releases Topline Data from Open-Label GBM Clinical Study
Kintara Therapeutics Inc. (NASDAQ: KTRA) has announced topline data from its newly-diagnosed adjuvant arm of the open-label second phase clinical trial being carried at the...
Abeona Therapeutics Inc (NASDAQ: ABEO) Recently Issued an Update on Its VIITAL Study and...
Abeona Therapeutics Inc (NASDAQ: ABEO) recently updated its phase 3 VITAL study to its shareholders and prospective investors. The company announced that it had...
MAKE IT MODERN
